Clinical trials
Aged clinical trials
Below are recruiting aged clinical trials, each written for real people, not researchers. We’re tracking 1,304 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07719049Recruiting
AI facial health check study for healthy adults
This study uses artificial intelligence to analyze facial photographs to see if health insights can be detected. It is for healthy adult volunteers and involves taking a photo of your face.
Boston, MassachusettsAges 18 years+ - NCT07516132RecruitingPhase 3
Long-term safety study of axitinib implant for wet macular degeneration
This study follows people who completed an earlier 2-year trial of OTX-TKI, a small implant placed in the eye to treat wet age-related macular degeneration (a condition causing vision loss). Researchers want to make sure the treatment remains safe over time.
Bakersfield, CaliforniaAges 50 years+ - NCT06056180Recruiting
Motor imagery training for balance in older adults
This study tests whether imagining moving your body (motor imagery training) can improve balance in older adults. It will compare this mental practice with usual activities to see if it helps prevent falls and improves stability.
Menteşe, MuğlaAges 60–80 - NCT07203365RecruitingPhase 3
RSV vaccine study for older adults in Sweden
This study tests a vaccine called Arexvy to see if it protects older adults from RSV, a virus that can cause serious lung infections. You must be born between 1965 and 1960 or before 1945, live in Sweden, and be medically stable.
SaltsjöbadenAges 60 years+ - NCT07461584Recruiting
Memory boost in older adults with optimal dosing
This study tests a safe, non-invasive brain stimulation method to see if it can improve memory in healthy older adults. It uses carefully chosen doses to find the best approach.
Boston, MassachusettsAges 65 years+ - NCT06141460RecruitingPhase 1/Phase 2
Gene therapy trial for wet age-related macular degeneration
This trial tests a new gene therapy called RRG001 for people with the 'wet' form of age-related macular degeneration. It aims to treat leaky blood vessels in the eye that can cause vision loss, possibly reducing the need for frequent eye injections.
Tianjin, Tianjin MunicipalityAges 50 years+ - NCT07441642RecruitingPhase 2
Testing FWY003 eye drops for geographic atrophy (dry AMD)
This trial tests a new eye drop called FWY003 against a placebo (an inactive drop) to see if it can slow the progression of geographic atrophy (the dry form of age-related macular degeneration). It may help people who have moderate vision loss from this condition.
Huntington Beach, CaliforniaAges 50 years+ - NCT05706896Recruiting
Cord blood plasma injections for dry macular degeneration
This trial tests whether injections made from umbilical cord blood “platelet-rich plasma” can improve vision in people with dry age-related macular degeneration (AMD) in both eyes. It targets older adults with specific vision levels and no major other eye or medical problems that could affect the results.
RomeAges 65 years+ - NCT07415707Recruiting
Reducing alcohol and taking probiotics for brain health in older adults
This study tests whether cutting back on alcohol and taking probiotics can improve memory and thinking in older adults who are heavy drinkers. If you are interested in drinking less, you may be able to join.
Miami, FloridaAges 65–84 - NCT07376148RecruitingPhase 4
Laser and serum treatment for skin quality in adults over 30
This trial tests a treatment that combines a fractional CO2 laser with a special serum containing hyaluronic acid, vitamin C, and sodium DNA to improve skin quality. It is for people over 30 with moderate skin concerns and lighter skin types.
Mexico City, Mexico CityAges 30 years+ - NCT07218523RecruitingPhase 3
Bowel cleansing study for children having a colonoscopy
This study tests a bowel-cleansing medicine called PLENVU against another medicine (sodium picosulfate) in children aged 1 to under 18 who need a colonoscopy. The goal is to see which one works better at cleaning the bowel before the procedure.
Edegem, AntwerpAges 1–17 - NCT06090253Recruiting
Sport exercise program for healthy aging over 60
This trial tests a program that uses sports and exercise to help people over 60 stay healthy and active. It looks at both how well the program works and how easy it is to put into practice.
Hong KongAges 60 years+ - NCT06788379Recruiting
Testing a new marker for egg damage in women having IVF
This trial studies a protein called CENP-V to see if it can help measure egg (oocyte) health. It includes women at different ages and those using frozen eggs, to find better ways to predict egg quality.
Seville, SEVILLAAges 18–45 - NCT06487039RecruitingPhase 2
EB-203 for wet age-related macular degeneration
This trial tests a new medicine called EB-203 for people with wet age-related macular degeneration (AMD), a condition that causes blurry vision. It aims to see if the treatment is safe and can help improve or stabilize vision.
BusanAges 50 years+ - NCT06536062Recruiting
Cord blood and platelet plasma for dry macular degeneration
This trial tests if a treatment made from umbilical cord blood and platelet-rich plasma can help people with dry age-related macular degeneration. The treatment is given as an injection into the eye, and the goal is to see if it slows vision loss or improves sight.
Rome, RomeAges 65 years+ - NCT06940037Recruiting
Aging biology and strength training in older adults
This study looks at how aging affects the way older adults respond to resistance training (exercises using weights or resistance bands). It compares two types of training to see which works better for improving mobility and strength.
Boston, MassachusettsAges 65 years+ - NCT06824285Recruiting
Brain wave markers in healthy aging
This study looks at how brain wave patterns change as people age normally, without any brain diseases. It may help researchers understand healthy aging better.
Rome, RomeAges 18 years+ - NCT07215390RecruitingPhase 2
Study of APL-3007 plus Syfovre for geographic atrophy
This trial tests whether a new drug called APL-3007, when added to your current Syfovre treatment, can slow the progression of geographic atrophy (an advanced form of dry age-related macular degeneration). It's for people who have already been on Syfovre for at least 6 months.
Gilbert, ArizonaAges 60 years+ - NCT05301192RecruitingEarly Phase 1
Study angiotensin-1-7 effects on hearts and blood vessels in older adults
This early-phase study tests how angiotensin-(1-7) affects blood vessels and the heart in people ages 65–80. It may help researchers understand how to improve cardiovascular function as we age.
Hershey, PennsylvaniaAges 65–80 - NCT07208279Recruiting
Cognitive Vitality Study: Can Axolt help memory?
This clinical trial is testing whether a special dietary supplement called Axolt can help keep your memory and thinking sharp as you get older. It is for healthy adults 55 and older who live independently and have no major memory problems.
West Palm Beach, FloridaAges 55 years+ - NCT07208318RecruitingEarly Phase 1
Restructuring brain signals for aging vision
This study tests a new way to help older adults improve their vision by retraining how the brain processes visual information. It may help with age-related vision changes.
Boston, MassachusettsAges 18 years+ - NCT07260500RecruitingPhase 2
Growth hormone study for short children born small for gestational age
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
Wuhan, HubeiAges 3 years+ - NCT07162168Recruiting
Using AI to measure bone age from abdominal CT scans
This study uses artificial intelligence to estimate bone age from standard abdominal CT scans. It may help researchers understand how bone age relates to health conditions without extra X-rays.
BeijingAges 18 years+ - NCT07121283Enrolling by invitation
AI for reading children's bone age X-rays
This trial uses artificial intelligence to help doctors assess bone age in children from a single X-ray. It compares AI results with radiologists' readings.
Taipei, TaiwanAges Any age
Hear when a new Aged trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for aged?
- Yes. Clin2 currently lists 1,304 recruiting aged studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a aged trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a aged trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.